Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Apr 1;20(4):657-662.
doi: 10.5664/jcsm.10968.

Apparent resolution of hypersomnia episodes in two patients with Kleine-Levin syndrome following treatment with the melatonin receptor agonist ramelteon

Dayana Dominguez  1 , Robert Rudock  1 , Stuart Tomko  1 , Sheel Pathak  1 , Emmanuel Mignot  2 , Amy Licis  1   3
Affiliations
Case Reports

Apparent resolution of hypersomnia episodes in two patients with Kleine-Levin syndrome following treatment with the melatonin receptor agonist ramelteon

Dayana Dominguez et al. J Clin Sleep Med. .

Abstract

Kleine-Levin syndrome (KLS) is a rare disorder characterized by episodic bouts of severe hypersomnia associated with cognitive and behavioral abnormalities and normal alertness and functioning in between episodes. The pathophysiology is unclear but may involve neurotransmitter abnormalities, hypothalamic/thalamic dysfunction, viral/autoimmune etiology, or circadian abnormalities. No single treatment has been shown to be reliably efficacious; lithium has demonstrated the most consistent efficacy, although many do not respond and its use is limited by side effects. Due to the evidence of circadian involvement, we hypothesized that strengthening circadian signals may ameliorate symptoms. Ramelteon is a potent melatonin receptor agonist. In this report, two patients with KLS are described with apparent resolution of hypersomnia episodes following ramelteon initiation.

Citation: Dominguez D, Rudock R, Tomko S, Pathak S, Mignot E, Licis A. Apparent resolution of hypersomnia episodes in two patients with Kleine-Levin syndrome following treatment with the melatonin receptor agonist ramelteon. J Clin Sleep Med. 2024;20(4):657-662.

Keywords: Kleine–Levin syndrome; hypersomnia; melatonin; pharmacology; ramelteon.

PubMed Disclaimer

Conflict of interest statement

All authors have seen and approved the manuscript. E.M. is funded by the Kleine–Levin Syndrome Foundation for work on this disease. The authors report no conflicts of interest. The authors report the off-label/investigational use of ramelteon for the treatment of Kleine–Levin syndrome.

References

    1. American Academy of Sleep Medicine . International Classification of Sleep Disorders. 3rd ed . Darien, IL: : American Academy of Sleep Medicine; ; 2014. .
    1. Arnulf I , Rico TJ , Mignot E . Diagnosis, disease course, and management of patients with Kleine-Levin syndrome . Lancet Neurol. 2012. ; 11 ( 10 ): 918 – 928 . - PubMed
    1. de Oliveira MM , Conti C , Prado GF . Pharmacological treatment for Kleine-Levin syndrome . Cochrane Database Syst Rev. 2016. ; 2016 ( 5 ): CD006685 . - PMC - PubMed
    1. Dauvilliers Y , Mayer G , Lecendreux M , et al. . Kleine-Levin syndrome: an autoimmune hypothesis based on clinical and genetic analyses . Neurology. 2002. ; 59 ( 11 ): 1739 – 1745 . - PubMed
    1. Ambati A , Hillary R , Leu-Semenescu S , et al. . Kleine-Levin syndrome is associated with birth difficulties and genetic variants in the TRANK1 gene loci . Proc Natl Acad Sci USA. 2021. ; 118 ( 12 ): e2005753118 . - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources